Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial.
Jolliffe DA, Vivaldi G, Chambers ES, Cai W, Li W, Faustini SE, Gibbons JM, Pade C, Coussens AK, Richter AG, McKnight Á, Martineau AR. Jolliffe DA, et al. Among authors: gibbons jm. Nutrients. 2022 Sep 16;14(18):3821. doi: 10.3390/nu14183821. Nutrients. 2022. PMID: 36145196 Free PMC article. Clinical Trial.
Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study.
Vivaldi G, Jolliffe DA, Faustini S, Shields AM, Holt H, Perdek N, Talaei M, Tydeman F, Chambers ES, Cai W, Li W, Gibbons JM, Pade C, McKnight Á, Shaheen SO, Richter AG, Martineau AR. Vivaldi G, et al. Among authors: gibbons jm. J Infect Dis. 2022 Nov 28;226(11):1903-1908. doi: 10.1093/infdis/jiac321. J Infect Dis. 2022. PMID: 35906930 Free PMC article.
Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
Reynolds CJ, Pade C, Gibbons JM, Butler DK, Otter AD, Menacho K, Fontana M, Smit A, Sackville-West JE, Cutino-Moguel T, Maini MK, Chain B, Noursadeghi M; UK COVIDsortium Immune Correlates Network; Brooks T, Semper A, Manisty C, Treibel TA, Moon JC; UK COVIDsortium Investigators; Valdes AM, McKnight Á, Altmann DM, Boyton R. Reynolds CJ, et al. Among authors: gibbons jm. Science. 2021 Apr 30;372(6549):1418-23. doi: 10.1126/science.abh1282. Online ahead of print. Science. 2021. PMID: 33931567 Free PMC article.
Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
Reynolds CJ, Gibbons JM, Pade C, Lin KM, Sandoval DM, Pieper F, Butler DK, Liu S, Otter AD, Joy G, Menacho K, Fontana M, Smit A, Kele B, Cutino-Moguel T, Maini MK, Noursadeghi M; COVIDsortium Immune Correlates Network‡; Brooks T, Semper A, Manisty C, Treibel TA, Moon JC; COVIDsortium Investigators‡; McKnight Á, Altmann DM, Boyton RJ. Reynolds CJ, et al. Among authors: gibbons jm. Science. 2022 Jan 14;375(6577):183-192. doi: 10.1126/science.abm0811. Epub 2021 Dec 2. Science. 2022. PMID: 34855510 Free PMC article.
Behçet's patients' response to COVID-19 vaccination.
Gokani B, Sacoor S, Leisegang GR, Ogunkolade W, Bibi A, Grigoriadou S, Pade C, Gibbons J, Senusi A, Fortune F. Gokani B, et al. Clin Immunol. 2023 Oct;255:109700. doi: 10.1016/j.clim.2023.109700. Epub 2023 Jul 22. Clin Immunol. 2023. PMID: 37482118
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.
Altmann DM, Reynolds CJ, Joy G, Otter AD, Gibbons JM, Pade C, Swadling L, Maini MK, Brooks T, Semper A, McKnight Á, Noursadeghi M, Manisty C, Treibel TA, Moon JC; COVIDsortium investigators; Boyton RJ. Altmann DM, et al. Among authors: gibbons jm. Nat Commun. 2023 Aug 23;14(1):5139. doi: 10.1038/s41467-023-40460-1. Nat Commun. 2023. PMID: 37612310 Free PMC article.
Curbside particulate matter and susceptibility to SARS-CoV-2 infection.
Miyashita L, Foley G, Semple S, Gibbons JM, Pade C, McKnight Á, Grigg J. Miyashita L, et al. Among authors: gibbons jm. J Allergy Clin Immunol Glob. 2023 Jul 8;2(4):100141. doi: 10.1016/j.jacig.2023.100141. eCollection 2023 Nov. J Allergy Clin Immunol Glob. 2023. PMID: 37781647 Free PMC article.
Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections.
Chandran A, Rosenheim J, Nageswaran G, Swadling L, Pollara G, Gupta RK, Burton AR, Guerra-Assunção JA, Woolston A, Ronel T, Pade C, Gibbons JM, Sanz-Magallon Duque De Estrada B, Robert de Massy M, Whelan M, Semper A, Brooks T, Altmann DM, Boyton RJ, McKnight Á, Captur G, Manisty C, Treibel TA, Moon JC, Tomlinson GS, Maini MK, Chain BM, Noursadeghi M; COVIDsortium Investigators. Chandran A, et al. Among authors: gibbons jm. Cell Rep Med. 2022 Mar 4;3(3):100557. doi: 10.1016/j.xcrm.2022.100557. eCollection 2022 Mar 15. Cell Rep Med. 2022. PMID: 35474751 Free PMC article.
55 results